Eisai, Biogen get US FDA approval for Alzheimer’s drug, apply for full approval
The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd 4523.T and Biogen Inc BIIB.O for patients in the ...
Stay up to date with the latest health news, wellness advice, medical research, and public health updates in Cyprus and around the world.